Basilea

Petri dish of cultured Candida auris fungi
Biotech

Basilea secures $39M as part of BARDA antifungal funding plan

Basilea Pharmaceutica has accessed the next tranche of U.S. government funding required to continue developing its pipeline of new antifungals.
James Waldron Jul 8, 2025 3:52am
MRSA comeback

Basilea opts not to take MRSA antibiotic into clinic

Feb 18, 2025 4:08am
Antibiotic-resistant bacteria

Basilea scores $268M BARDA funding for antifungals, antibiotics

Sep 19, 2024 7:45am
Photo of three hands placing together three white puzzle pieces

Basilea continues pipeline refill with Pfizer antifungal

Nov 13, 2023 8:15am
handshake deal shake hand arrows ok yes

Basilea anti-infective strategy restarts with $2M antifungal buy

Oct 19, 2023 7:25am
target maze risk risky arrow labyrinth tricky

Basilea hands back antifungal 9 months after licensing it

Jan 17, 2023 7:15am